Cytopoint Injection for Dogs is an innovative medication designed to provide relief to dogs suffering from atopic dermatitis, a common and often debilitating skin condition. Cytopoint helps reduce the itchiness and inflammation associated with atopic dermatitis, allowing dogs to live more comfortably.
Cytopoint Solution works in the same way as your dog’s own immune system. It specifically targets and neutralises one of the main proteins that send itch signals to your dog’s brain that trigger scratching, licking, and chewing. Breaking the itch-scratch cycle allows irritated skin to heal.
This product is administered by monthly injection. Ercanol Injectable 100ml
Dosage and Administration
For subcutaneous use.
Avoid excessive shaking or foaming of the solution. Administer the entire contents (1 ml) of the Cytopoint vial.
For dogs above 40 kg, the contents of more than one vial of Cytopoint are required to administer in a single dose.
In those cases, withdraw the appropriate content from each required vial into the same syringe. To allow for mixing of the solution, gently invert the syringe three or four times before administering. Dosage and treatment schedule
The recommended minimum dose is 1 mg/kg bodyweight, once a month.
Active Ingredient
Presentation
2 x 1ml vials of
10mg (3kg-10kg)
20mg (10kg-20kg)
30mg (20kg-30kg)
40mg (30kg-40kg)
Important Information
Remember to store this product upright in its original packaging and refrigerate between 2 & 8°c.
Your medicine will be delivered via courier in specialist, sustainable insulated packaging with ice packs to ensure it reaches you in the best condition. Dispatches may be temporarily delayed during hot weather due to increased temperatures during transit. Sangre De Tigre 50ml
Contra-indications, warnings, etc
Do not use Cytopoint in cases of hypersensitivity to the active substance or to any of the excipients. Do not use in dogs less than 3kg bodyweight. Lokivetmab may induce transient or persistent anti-drug antibodies.
The induction of such antibodies is uncommon and may have no effect (transient anti-drug antibodies) or may result in a noticeable decrease in efficacy (persistent anti-drug antibodies) in animals that responded to treatment previously.
In cases of atopic dermatitis, it is recommended to investigate and treat complicating factors, such as bacterial, fungal or parasitic infections/infestations (e.g. flea and mange).
It is recommended to monitor dogs for bacterial infections associated with atopic dermatitis, especially during the first weeks of treatment. If no or limited response is observed within one month after initial dosing, an improvement in response may be observed after administration of a second dose one month later. However, if the animal does not show a better response after the second dose, the veterinary surgeon should consider alternative treatments.
The safety of the veterinary medicinal product has not been established during pregnancy and lactation; therefore its use is not recommended during pregnancy, lactation or in breeding animals.
